Form 8-K - Current report:
SEC Accession No. 0001193125-25-075102
Filing Date
2025-04-08
Accepted
2025-04-08 07:45:29
Documents
18
Period of Report
2025-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d943675d8k.htm   iXBRL 8-K 34962
2 EX-4.1 d943675dex41.htm EX-4.1 80741
3 EX-5.1 d943675dex51.htm EX-5.1 15442
4 EX-10.1 d943675dex101.htm EX-10.1 156223
5 EX-99.1 d943675dex991.htm EX-99.1 11154
9 GRAPHIC g943675g0408083746194.jpg GRAPHIC 3089
  Complete submission text file 0001193125-25-075102.txt   505054

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20250407.xsd EX-101.SCH 2861
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20250407_lab.xml EX-101.LAB 17234
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20250407_pre.xml EX-101.PRE 10819
20 EXTRACTED XBRL INSTANCE DOCUMENT d943675d8k_htm.xml XML 3501
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 25820298
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)